Current Oncology (Aug 2023)

Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation Technique

  • Andrea Vavassori,
  • Giovanni Mauri,
  • Giovanni Carlo Mazzola,
  • Federico Mastroleo,
  • Guido Bonomo,
  • Stefano Durante,
  • Dario Zerini,
  • Giulia Marvaso,
  • Giulia Corrao,
  • Elettra Dorotea Ferrari,
  • Elena Rondi,
  • Sabrina Vigorito,
  • Federica Cattani,
  • Franco Orsi,
  • Barbara Alicja Jereczek-Fossa

DOI
https://doi.org/10.3390/curroncol30090576
Journal volume & issue
Vol. 30, no. 9
pp. 7926 – 7935

Abstract

Read online

In this technical development report, we present the strategic placement of fiducial markers within the prostate under the guidance of computed tomography (CT) and electromagnetic navigation (EMN) for the delivery of ultra-hypofractionated cyberknife (CK) therapy in a patient with localized prostate cancer (PCa) who had previously undergone chemo-radiotherapy for rectal cancer and subsequent abdominoperineal resection due to local recurrence. The patient was positioned in a prone position with a pillow under the pelvis to facilitate access, and an electromagnetic fiducial marker was placed on the patient’s skin to establish a stable position. CT scans were performed to plan the procedure, mark virtual points, and simulate the needle trajectory using the navigation system. Local anesthesia was administered, and a 21G needle was used to place the fiducial markers according to the navigation system information. A confirmatory CT scan was obtained to ensure proper positioning. The implantation procedure was safe, without any acute side effects such as pain, hematuria, dysuria, or hematospermia. Our report highlights the ability to use EMN systems to virtually navigate within a pre-acquired imaging dataset in the interventional room, allowing for non-conventional approaches and potentially revolutionizing fiducial marker positioning, offering new perspectives for PCa treatment in selected cases.

Keywords